Dr. Michael D. Bennett, founder and president of Retina Institute of Hawaii, recently served on the U.S. Food and Drug Administration (FDA) Ophthalmic Devices Advisory Panel. Appointed in 2012, Dr. Bennett was part of a 23-member panel that has expertise in retinal disease, low vision, electrophysiology and other specialties. Panel members included doctors from Washington, D.C., Houston, TX, Saint Louis, MO, Chicago, IL and Brooklyn, N.Y. Panel deliberations provide the FDA with expert knowledge and experience on new issues, devices or unanticipated safety and effectiveness questions. The FDA welcomes and values open debates raising new ideas and perspectives. Dr. Bennett’s knowledge and capabilities added to the medical devices panel in reviewing and approving the newest system treatment.
